Literature DB >> 10970417

Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system.

A Tsakris1, A Pantazi, S Pournaras, A Maniatis, A Polyzou, D Sofianou.   

Abstract

Introduction of the Vitek GNS-506 susceptibility testing cards in the Hippokration General Hospital, Thessaloniki, Greece, resulted in an apparently high prevalence of imipenem-resistant Acinetobacter baumannii. When 35 of these isolates were further tested by disk diffusion, broth microdilution, and agar dilution assays, 32 were imipenem sensitive by all tests and three were sensitive or intermediate, depending on the method. The pseudoresistant acinetobacters did not form a genetically homogeneous group. It is suggested that the detection of imipenem-resistant A. baumannii isolates by this system should be confirmed by an additional susceptibility test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970417      PMCID: PMC87420     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  False resistance to imipenem with a microdilution susceptibility testing system.

Authors:  E J O'Rourke; K G Lambert; K C Parsonnet; A B Macone; D A Goldmann
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

3.  Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa.

Authors:  Y Carmeli; K Eichelberger; D Soja; J Dakos; L Venkataraman; P DeGirolami; M Samore
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 4.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny.

Authors:  M L Riccio; N Franceschini; L Boschi; B Caravelli; G Cornaglia; R Fontana; G Amicosante; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  G V Doern; A B Brueggemann; R Perla; J Daly; D Halkias; R N Jones; M A Saubolle
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

8.  Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii.

Authors:  H Seifert; A Schulze; R Baginski; G Pulverer
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

10.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

View more
  6 in total

1.  "All-in-one-plate" E-test and disk diffusion susceptibility co-testing for multiresistant Acinetobacter baumannii.

Authors:  J Gilad; M Giladi; F Poch; Y Aharoni; D Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

Review 2.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 4.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates.

Authors:  Jing Jin; Zhen-Jiang Li; Shu-Wei Wang; Shan-Mei Wang; De-Hai Huang; Ya-Hui Li; Yun-Yun Ma; Jin Wang; Fang Liu; Xiang-Dong Chen; Guang-Xing Li; Xiao-Ting Wang; Zhong-Quan Wang; Guo-Qiang Zhao
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605

6.  Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.

Authors:  Canan Kulah; Elif Aktas; Fusun Comert; Nagihan Ozlu; Isin Akyar; Handan Ankarali
Journal:  BMC Infect Dis       Date:  2009-03-16       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.